News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
June, 2025
June 2025
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
SIOP Releases Agenda for Childhood Cancer Survivor’s Week Event
SIOP/LinkedIn
Jun 25, 2025, 07:10

SIOP Releases Agenda for Childhood Cancer Survivor’s Week Event

International Society of Paediatric Oncology – SIOP posted on LinkedIn:

“AGENDA NOW AVAILABLE.
Join us on 28 June 2025 for this Survivor’s Week event, celebrating survivors of childhood cancer.”

More posts featuring SIOP.

cancer Childhood Cancer OncoDaily Oncology SIOP International Survivor's Week
Special Coverage
Blog
Jun 25, 2025, 07:10
SIOP Releases Agenda for Childhood Cancer Survivor’s Week Event
Blog
Jun 25, 2025, 07:04
ESMO Presents Findings on ADC Target Expression in Ovarian Cancer at ESMO Gynae25
Blog
Jun 25, 2025, 06:57
Ruben Mesa Welcomes Nike Onifade as Administrative Leader for Advocate Health Cancer Service Line
Blog
Jun 25, 2025, 06:49
Angela Mastronuzzi: Honored to Receive “Celebrating Local Excellence” Award in Statte Gala
Blog
Jun 25, 2025, 06:44
Applications are Open for European School of Oncology's Masterclass in Clinical Oncology - Autumn Edition
Blog
Jun 25, 2025, 06:37
Mahdi Sheikh: Lung Cancer Screening in Europe is a Golden Opportunity to Tackle Tobacco Use with Scalable
Blog
Jun 25, 2025, 06:37
Devika Das Joins the University of Mississippi as Division Director of Hematology and Oncology
Blog
Jun 25, 2025, 06:25
Chandler Park Thanks Colleagues for Making MLS Nashville 2025 ASCO Review a Fun Educational Event
Blog
Jun 25, 2025, 06:18
Andrea Necchi: SURE Trials are on a Graduation Thesis!
Oncolibrary
Jun 25, 2025, 06:14
How Chemotherapy Affects Cancer and Normal Cells: Mechanisms, Side Effects and Long-Term Risks
Societies
Jun 25, 2025, 05:53
20 Posts Not to Miss from ESMO Gynaecological Cancers Congress 2025
Insight
Jun 25, 2025, 05:45
Galip Can Uyar: Female Patients Showed Better Outcomes with Atezolizumab/Bevacizumab